These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 17887772)
41. Phenolics removal from transgenic Lemna minor extracts expressing mAb and impact on mAb production cost. Barros GO; Woodard SL; Nikolov ZL Biotechnol Prog; 2011; 27(2):410-8. PubMed ID: 21485031 [TBL] [Abstract][Full Text] [Related]
42. Application of mixed mode resins for the purification of antibodies. Voitl A; Müller-Späth T; Morbidelli M J Chromatogr A; 2010 Sep; 1217(37):5753-60. PubMed ID: 20701917 [TBL] [Abstract][Full Text] [Related]
43. Countercurrent tangential chromatography for large-scale protein purification. Shinkazh O; Kanani D; Barth M; Long M; Hussain D; Zydney AL Biotechnol Bioeng; 2011 Mar; 108(3):582-91. PubMed ID: 20939008 [TBL] [Abstract][Full Text] [Related]
44. Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process. Chen J; Tetrault J; Ley A J Chromatogr A; 2008 Jan; 1177(2):272-81. PubMed ID: 17709111 [TBL] [Abstract][Full Text] [Related]
45. Weak partitioning chromatography for anion exchange purification of monoclonal antibodies. Kelley BD; Tobler SA; Brown P; Coffman JL; Godavarti R; Iskra T; Switzer M; Vunnum S Biotechnol Bioeng; 2008 Oct; 101(3):553-66. PubMed ID: 18727127 [TBL] [Abstract][Full Text] [Related]
46. Viral clearance using disposable systems in monoclonal antibody commercial downstream processing. Zhou JX; Solamo F; Hong T; Shearer M; Tressel T Biotechnol Bioeng; 2008 Jun; 100(3):488-96. PubMed ID: 18438883 [TBL] [Abstract][Full Text] [Related]
47. Chromatography-free recovery of biopharmaceuticals through aqueous two-phase processing. Azevedo AM; Rosa PA; Ferreira IF; Aires-Barros MR Trends Biotechnol; 2009 Apr; 27(4):240-7. PubMed ID: 19251328 [TBL] [Abstract][Full Text] [Related]
48. An engineering and economic evaluation of wet and dry pre-fractionation processes for dry-grind ethanol facilities. Lin T; Rodríguez LF; Li C; Eckhoff SR Bioresour Technol; 2011 Oct; 102(19):9013-9. PubMed ID: 21778050 [TBL] [Abstract][Full Text] [Related]
50. High-throughput process development: determination of dynamic binding capacity using microtiter filter plates filled with chromatography resin. Bergander T; Nilsson-Välimaa K; Oberg K; Lacki KM Biotechnol Prog; 2008; 24(3):632-9. PubMed ID: 18454563 [TBL] [Abstract][Full Text] [Related]
51. Automatic purification of monoclonal antibodies. van der Voort K Dev Biol Stand; 1990; 71():87-90. PubMed ID: 2401390 [TBL] [Abstract][Full Text] [Related]
52. Two-dimensional fluorescence difference gel electrophoresis for comparison of affinity and non-affinity based downstream processing of recombinant monoclonal antibody. Grzeskowiak JK; Tscheliessnig A; Toh PC; Chusainow J; Lee YY; Wong N; Jungbauer A J Chromatogr A; 2009 Jun; 1216(24):4902-12. PubMed ID: 19423113 [TBL] [Abstract][Full Text] [Related]
53. Analysis of viral clearance unit operations for monoclonal antibodies. Miesegaes G; Lute S; Brorson K Biotechnol Bioeng; 2010 Jun; 106(2):238-46. PubMed ID: 20073086 [TBL] [Abstract][Full Text] [Related]
54. Simple separation of DNA in antibody purification. Christensen PA; Danielczyk A; Stahn R; Goletz S Protein Expr Purif; 2004 Oct; 37(2):468-71. PubMed ID: 15358372 [TBL] [Abstract][Full Text] [Related]
55. A potential generic downstream process using Cibracon Blue resin at very high loading capacity produces a highly purified monoclonal antibody preparation from cell culture harvest. Riske F; Smith M; Menon M; Goetschalck S; Goidsenhoven IV; Krul A; Pimpaneau V; Renaers I; Van Tichelt N; Van Houdt K; Hayes M; Lawrence C; Bigelow R; Schroeder J J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):108-15. PubMed ID: 16893691 [TBL] [Abstract][Full Text] [Related]
56. Implementation of advanced technologies in commercial monoclonal antibody production. Zhou JX; Tressel T; Yang X; Seewoester T Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247 [TBL] [Abstract][Full Text] [Related]
57. Quantifying process tradeoffs in the operation of chromatographic sequences. Ngiam SH; Bracewell DG; Zhou Y; Titchener-Hooker NJ Biotechnol Prog; 2003; 19(4):1315-22. PubMed ID: 12892496 [TBL] [Abstract][Full Text] [Related]
58. Improved process analytical technology for protein a chromatography using predictive principal component analysis tools. Hou Y; Jiang C; Shukla AA; Cramer SM Biotechnol Bioeng; 2011 Jan; 108(1):59-68. PubMed ID: 20672251 [TBL] [Abstract][Full Text] [Related]
59. Parallel, high-throughput purification of recombinant antibodies for in vivo cell assays. Bannister D; Wilson A; Prowse L; Walsh M; Holgate R; Jermutus L; Wilkinson T Biotechnol Bioeng; 2006 Aug; 94(5):931-7. PubMed ID: 16570309 [TBL] [Abstract][Full Text] [Related]
60. Application of a novel affinity adsorbent for the capture and purification of recombinant factor VIII compounds. McCue JT; Selvitelli K; Walker J J Chromatogr A; 2009 Nov; 1216(45):7824-30. PubMed ID: 19800068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]